临床使用CathPCI注册风险评分及其验证以预测长期死亡率
Majeed Zahalka1, Erick Sanchez-Jimenez1, Yaniv Levi1
1Cardiology Department, Hillel Yaffe Medical Center, Hadera, Israel; Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.
The American journal of cardiology
|July 2, 2023
概括
一个新的风险评分准确地预测了高风险患者皮肤冠状动脉干预 (PCI) 后的死亡率. 这个经过验证的模型改进了急性冠状动脉缺血的现有工具,为住院,30天和1年的结果提供了更广泛的适用性.
科学领域:
- 心脏病学 心脏病学
- 临床风险预测预测
- 健康 结果 研究 研究 结果
背景情况:
- 对于皮肤冠状动脉干预 (PCI) 死亡率的现有风险模型在复杂的高风险患者群体中具有有限的实用性.
- 最近使用美国心脏病学会CathPCI注册数据的床边模型证明了医院死亡率的预测有所改善.
研究的目的:
- 为了验证美国心脏病学会 (ACC) CathPCI注册风险评分在急性冠状动脉缺血患者的不同人群.
- 评估模型预测住院,30天和1年死亡率的能力.
主要方法:
- CathPCI风险评分应用于以色列急性冠状动脉综合征调查 (ACSIS) 队列,包括接受PCI的急性心肌梗塞住院的1,155名患者.
- 数据包括住院,30天和1年的死亡结果.
主要成果:
- 在CathPCI风险评分中,医院住院死亡率 (AUC 0.96) 和30天死亡率 (AUC 0.96) 的预测准确度很高,一年死亡率 (AUC 0.88) 的准确度很好.
- ACSIS队列包括患有脆弱状态,大动脉狭窄,耐火性休克和心脏骤停后等疾病的高风险患者,表明该模型在复杂病例中的适用性.
结论:
- ACC CathPCI注册风险评分在ACSIS队列中得到验证,证实了其在预测急性冠状动脉缺血患者死亡率方面的有效性.
- 该模型显示了比以前的工具更广泛的应用范围,包括其用于预测30天和1年的死亡率在不同的高风险患者群体的实用性.
相关概念视频
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
42
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
42
01:28Cardiac Catheterization I: Pre-Procedure Overview
72
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
72
01:27Coronary Artery Disease V: Interprofessional Care
10
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
10
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
148
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
148
01:30Acute Coronary Syndrome III: Diagnostic Studies
10
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
10